BE896895A - Enzyme analogue a la pepsine leucocytaire humaine et compositions et agents therapeutiques qui la contiennent. - Google Patents

Enzyme analogue a la pepsine leucocytaire humaine et compositions et agents therapeutiques qui la contiennent.

Info

Publication number
BE896895A
BE896895A BE0/210886A BE210886A BE896895A BE 896895 A BE896895 A BE 896895A BE 0/210886 A BE0/210886 A BE 0/210886A BE 210886 A BE210886 A BE 210886A BE 896895 A BE896895 A BE 896895A
Authority
BE
Belgium
Prior art keywords
immuno
activity against
pepsin
human
tumour
Prior art date
Application number
BE0/210886A
Other languages
English (en)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of BE896895A publication Critical patent/BE896895A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE0/210886A 1982-05-31 1983-05-31 Enzyme analogue a la pepsine leucocytaire humaine et compositions et agents therapeutiques qui la contiennent. BE896895A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000213 WO1983004260A1 (fr) 1982-05-31 1982-05-31 Enzyme analogue de la pepsine de leucocyte humain et agent therapeutique contenant cette enzyme en tant qu'ingredient effectif pour le traitement de troubles allergiques, de maladies auto-immunitaires et de tumeurs

Publications (1)

Publication Number Publication Date
BE896895A true BE896895A (fr) 1983-09-16

Family

ID=13762278

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210886A BE896895A (fr) 1982-05-31 1983-05-31 Enzyme analogue a la pepsine leucocytaire humaine et compositions et agents therapeutiques qui la contiennent.

Country Status (11)

Country Link
US (1) US4591504A (fr)
AU (2) AU8459882A (fr)
BE (1) BE896895A (fr)
CA (1) CA1207262A (fr)
DE (1) DE3319360C2 (fr)
FR (1) FR2527630B1 (fr)
GB (1) GB2125046B (fr)
IT (1) IT1172264B (fr)
NL (1) NL8301934A (fr)
SE (1) SE8303050L (fr)
WO (1) WO1983004260A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995221A (ja) * 1982-11-20 1984-06-01 Mochida Pharmaceut Co Ltd 食細胞機能調節作用を有する医薬組成物
ES2054641T3 (es) * 1987-09-30 1994-08-16 Mucos Emulsions Gmbh Utilizacion de enzimas catabolicas para la preparacion de un medicamento destinado a combatir la inmunodeficiencia adquirida (sida) y sus etapas previas (sla y crs).
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
JP2711436B2 (ja) * 1995-02-22 1998-02-10 マルホ株式会社 アレルギー治療剤及びアレルギー対応食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US3796636A (en) * 1972-07-14 1974-03-12 Wilson Pharm & Chem Corp Process for preparing high activity pepsin
US4229540A (en) * 1979-07-02 1980-10-21 Cutter Laboratories, Inc. Hydrolase purified from human plasma

Also Published As

Publication number Publication date
IT8348383A0 (it) 1983-05-27
DE3319360A1 (de) 1983-12-01
NL8301934A (nl) 1983-12-16
GB2125046A (en) 1984-02-29
GB2125046B (en) 1985-08-07
GB8314727D0 (en) 1983-07-06
FR2527630B1 (fr) 1986-07-11
WO1983004260A1 (fr) 1983-12-08
SE8303050D0 (sv) 1983-05-30
CA1207262A (fr) 1986-07-08
SE8303050L (sv) 1983-12-01
AU547166B2 (en) 1985-10-10
IT1172264B (it) 1987-06-18
AU1507283A (en) 1984-01-19
DE3319360C2 (de) 1986-10-09
US4591504A (en) 1986-05-27
FR2527630A1 (fr) 1983-12-02
AU8459882A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
MY112405A (en) Method of tumer treatment.
DK0651636T3 (da) Kemoterapi for cancer
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
WO2003102136A3 (fr) Anticorps se fixant specifiquement a la neurokinine b
WO2002039999B1 (fr) Inhibition d'angiogenese du type endostatine
Kocher et al. Long-term survival after brain metastases in breast cancer
SE8303050D0 (sv) Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex
Settle Akathisia and sertraline.
JPS54126723A (en) Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
MY141805A (en) Radioactive arsenic-containing compounds and their uses in the treatment of tumors
NZ287291A (en) Tri-aryl-substituted alanineamide derivatives, analogues and medicaments
IL147810A0 (en) Antitumor antibodies, proteins and uses thereof
IL151335A0 (en) 103p2d6: tissue specific protein highly expressed in various cancers
EP0100366A1 (fr) Agent de traitement d'allergies de maladies du complexe immunitaire et de tumeurs
GEP19991535B (en) Process for the Preparation of 7-Hydroxy Taxanes
DE602004019141D1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide
JPS57206623A (en) Remedy for allergic disease
Tow Radioimmunoassay follow-up of hydatidiform mole
WO2001088084A3 (fr) Nouveau polypeptide, superoxyde dismutase 11, et polynucleotide codant pour ce polypeptide
Cleveland CONSECUTIVE HERPES ZOSTER AND VARICELLA, WITH VARICELLA IN A CONTACT
CN119280256A (zh) 人参皂苷Rh4在制备防治记忆力减退药物中的用途
Gul'chiĭ et al. General trends in the pathomorphosis of surgical diseases of the thyroid after the Chernobyl catastrophe
WO2001075023A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide
Barsukov et al. Preoperative thermoradiotherapy in the combined treatment of rectal tumors is the inferior ampullar segmentŏ
JPS565069A (en) Settling dreg in soy sauce

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MOCHIDA PHARMACEUTICAL CO. LTD

Effective date: 19870531